335 related articles for article (PubMed ID: 26582044)
1. Nicotine and Toxicant Exposure among U.S. Smokeless Tobacco Users: Results from 1999 to 2012 National Health and Nutrition Examination Survey Data.
Rostron BL; Chang CM; van Bemmel DM; Xia Y; Blount BC
Cancer Epidemiol Biomarkers Prev; 2015 Dec; 24(12):1829-37. PubMed ID: 26582044
[TBL] [Abstract][Full Text] [Related]
2. Biomarkers of exposure among U.S. cigar smokers: an analysis of 1999-2012 National Health and Nutrition Examination Survey (NHANES) data.
Chen J; Kettermann A; Rostron BL; Day HR
Cancer Epidemiol Biomarkers Prev; 2014 Dec; 23(12):2906-15. PubMed ID: 25380733
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of carcinogen exposure in people who used "reduced exposure" tobacco products.
Hatsukami DK; Lemmonds C; Zhang Y; Murphy SE; Le C; Carmella SG; Hecht SS
J Natl Cancer Inst; 2004 Jun; 96(11):844-52. PubMed ID: 15173268
[TBL] [Abstract][Full Text] [Related]
4. Exposure to a Tobacco-Specific Carcinogen Among Adolescent Smokeless Tobacco Users in Rural California, United States.
Chaffee BW; Jacob P; Couch ET; Benowitz NL
Nicotine Tob Res; 2020 Oct; 22(10):1764-1771. PubMed ID: 31504879
[TBL] [Abstract][Full Text] [Related]
5. Metabolites of a tobacco-specific nitrosamine, 4-(methylnitrosamino)- 1-(3-pyridyl)-1-butanone (NNK), in the urine of smokeless tobacco users: relationship between urinary biomarkers and oral leukoplakia.
Kresty LA; Carmella SG; Borukhova A; Akerkar SA; Gopalakrishnan R; Harris RE; Stoner GD; Hecht SS
Cancer Epidemiol Biomarkers Prev; 1996 Jul; 5(7):521-5. PubMed ID: 8827356
[TBL] [Abstract][Full Text] [Related]
6. Similar exposure to a tobacco-specific carcinogen in smokeless tobacco users and cigarette smokers.
Hecht SS; Carmella SG; Murphy SE; Riley WT; Le C; Luo X; Mooney M; Hatsukami DK
Cancer Epidemiol Biomarkers Prev; 2007 Aug; 16(8):1567-72. PubMed ID: 17684130
[TBL] [Abstract][Full Text] [Related]
7. Exposure to Toxicants Associated With Use and Transitions Between Cigarettes, e-Cigarettes, and No Tobacco.
Dai H; Benowitz NL; Achutan C; Farazi PA; Degarege A; Khan AS
JAMA Netw Open; 2022 Feb; 5(2):e2147891. PubMed ID: 35142830
[TBL] [Abstract][Full Text] [Related]
8. Biomarkers of Exposure among Adult Smokeless Tobacco Users in the Population Assessment of Tobacco and Health Study (Wave 1, 2013-2014).
Cheng YC; Reyes-Guzman CM; Christensen CH; Rostron BL; Edwards KC; Wang L; Feng J; Jarrett JM; Ward CD; Xia B; Kimmel HL; Conway K; Leggett C; Taylor K; Lawrence C; Niaura R; Travers MJ; Hyland A; Hecht SS; Hatsukami DK; Goniewicz ML; Borek N; Blount BC; van Bemmel DM
Cancer Epidemiol Biomarkers Prev; 2020 Mar; 29(3):659-667. PubMed ID: 31988072
[TBL] [Abstract][Full Text] [Related]
9. Tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in smokers in the United States: NHANES 2007-2008.
Xia Y; Bernert JT; Jain RB; Ashley DL; Pirkle JL
Biomarkers; 2011 Mar; 16(2):112-9. PubMed ID: 21114376
[TBL] [Abstract][Full Text] [Related]
10. A Longitudinal Study of Exposure to Tobacco-Related Toxicants and Subsequent Respiratory Symptoms Among U.S. Adults with Varying E-cigarette Use Status.
Dai H; Khan AS
Nicotine Tob Res; 2020 Dec; 22(Suppl 1):S61-S69. PubMed ID: 33320254
[TBL] [Abstract][Full Text] [Related]
11. TSNA Exposure: Levels of NNAL Among Canadian Tobacco Users.
Czoli CD; Hammond D
Nicotine Tob Res; 2015 Jul; 17(7):825-30. PubMed ID: 25481919
[TBL] [Abstract][Full Text] [Related]
12. Exposure to nicotine and a tobacco-specific carcinogen increase with duration of use of smokeless tobacco.
Hecht SS; Carmella SG; Edmonds A; Murphy SE; Stepanov I; Luo X; Hatsukami DK
Tob Control; 2008 Apr; 17(2):128-31. PubMed ID: 18375734
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Nicotine and Toxicant Exposure in Users of Electronic Cigarettes and Combustible Cigarettes.
Goniewicz ML; Smith DM; Edwards KC; Blount BC; Caldwell KL; Feng J; Wang L; Christensen C; Ambrose B; Borek N; van Bemmel D; Konkel K; Erives G; Stanton CA; Lambert E; Kimmel HL; Hatsukami D; Hecht SS; Niaura RS; Travers M; Lawrence C; Hyland AJ
JAMA Netw Open; 2018 Dec; 1(8):e185937. PubMed ID: 30646298
[TBL] [Abstract][Full Text] [Related]
14. Tobacco-Specific Nitrosamines (NNAL, NNN, NAT, and NAB) Exposures in the US Population Assessment of Tobacco and Health (PATH) Study Wave 1 (2013-2014).
Xia B; Blount BC; Guillot T; Brosius C; Li Y; Van Bemmel DM; Kimmel HL; Chang CM; Borek N; Edwards KC; Lawrence C; Hyland A; Goniewicz ML; Pine BN; Xia Y; Bernert JT; De Castro BR; Lee J; Brown JL; Arnstein S; Choi D; Wade EL; Hatsukami D; Ervies G; Cobos A; Nicodemus K; Freeman D; Hecht SS; Conway K; Wang L
Nicotine Tob Res; 2021 Feb; 23(3):573-583. PubMed ID: 32716026
[TBL] [Abstract][Full Text] [Related]
15. Biomarkers of Exposure among U.S. Adult Cigar Smokers: Population Assessment of Tobacco and Health (PATH) Study Wave 1 (2013-2014).
Chang CM; Rostron BL; Chang JT; Corey CG; Kimmel HL; Sosnoff CS; Goniewicz ML; Edwards KC; Hatsukami DK; Wang Y; Del Valle-Pinero AY; Yang M; Travers MJ; Arnstein S; Taylor K; Conway K; Ambrose BK; Borek N; Hyland A; Wang L; Blount BC; van Bemmel DM
Cancer Epidemiol Biomarkers Prev; 2019 May; 28(5):943-953. PubMed ID: 30733305
[TBL] [Abstract][Full Text] [Related]
16. Menthol cigarettes, race/ethnicity, and biomarkers of tobacco use in U.S. adults: the 1999-2010 National Health and Nutrition Examination Survey (NHANES).
Jones MR; Apelberg BJ; Tellez-Plaza M; Samet JM; Navas-Acien A
Cancer Epidemiol Biomarkers Prev; 2013 Feb; 22(2):224-32. PubMed ID: 23250935
[TBL] [Abstract][Full Text] [Related]
17. Mass spectrometric quantitation of nicotine, cotinine, and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in human toenails.
Stepanov I; Feuer R; Jensen J; Hatsukami D; Hecht SS
Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2378-83. PubMed ID: 17164359
[TBL] [Abstract][Full Text] [Related]
18. NNAL exposure by race and menthol cigarette use among U.S. smokers.
Rostron B
Nicotine Tob Res; 2013 May; 15(5):950-6. PubMed ID: 23089487
[TBL] [Abstract][Full Text] [Related]
19. Potential reduced exposure products (PREPs) for smokeless tobacco users: clinical evaluation methodology.
Gray JN; Breland AB; Weaver M; Eissenberg T
Nicotine Tob Res; 2008 Sep; 10(9):1441-8. PubMed ID: 19023835
[TBL] [Abstract][Full Text] [Related]
20. Associations of Smokeless Tobacco Use With Cardiovascular Disease Risk: Insights From the Population Assessment of Tobacco and Health Study.
Rezk-Hanna M; Warda US; Stokes AC; Fetterman J; Li J; Macey PM; Darawad M; Song Y; Ben Taleb Z; Brecht ML; Benowitz NL
Nicotine Tob Res; 2022 Jun; 24(7):1063-1070. PubMed ID: 34999825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
